amr industry alliance
The AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable solutions to curb antimicrobial resistance, with over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations joining forces.read more
We are uniting efforts to reduce the development of antimicrobial resistance, invest in R&D to meet public health needs and improve access to antibiotics, vaccines and diagnostics.
In 2020, the Alliance published its second progress report that provides unique insights into the practical steps its members are taking to respond to AMR. The findings of the report illustrate both the challenges the healthcare sector faces in tackling AMR and how the industry is essential to winning this battle.
Our case studies provide snap-shots from across the life-sciences industry, share information on the tangible steps we are taking to invest in new research to develop new antibiotics and vaccines, prevent infection ,and improve appropriate use of antibiotics.
The AMR Industry Alliance is currently seeking proposals to support the work of its Access Working Group. The duration of this consultancy is defined for a period of approximately 6 months, starting 22 October 2021 (or as soon as the procurement process is completed) and ending 28 February 2022 when the deliverables have been approved by the AMR Industry Alliance Board. The consultancy will be conducted under the overall guidance of the AMR Industry Alliance Access Working Group Lead and Core Team. The Consultancy will be home-based, from any country.Read more
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrobial resist...Read more
To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrob...Read more
amr in numbers
Life-sciences at the forefront of the battle against AMR
Development of National Action Plans
from the blog
Sepsis is a devastating condition resulting from a dysregulated immune system response to infection, which can lead to organ failure and death. Each year, sepsis affects close to 50 million people globally, of whom more than 40% are children under age 5 particularly in low- and middle-income countri...Read more view all